Ashwagandha vs L-Theanine: Which Is Better for Stress?
Both score anxiety 7.5–8.0/10, so the tie-breaker is time. L-theanine works in about an hour and you take it when you need it. Ashwagandha takes eight weeks and…
- Ashwagandha
- L-Theanine
Every intervention Outliyr has scored for deep and rem sleep, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for deep and rem sleep; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
24 of 84 evaluated interventions score 3.0+ out of 10 for deep and rem sleep · 2 comparisons
Bannai 2012 anchors the most relevant signal. Glycine fits sleep architecture because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the endpoint. The score stays bounded because…
SMR neurofeedback has a plausible sleep-architecture target and small clinical studies, including Cortoos 2010 in primary insomnia. The modern pooled sleep evidence is not clearly favorable, so this remains a secondary use…
Evidence from a Cochrane review of nine trials (7111 participants) shows tirzepatide produces modest weight loss versus placebo Franco et al. 2025. The drug's primary impact on sleep comes from secondary effects:…
Lang 2024 supports direction more than certainty. The existing rationale points to this narrower claim: Moderate aerobic training can improve sleep architecture over time, especially in sedentary adults and people with mild…
The evidence points to a plausible use case without proving a universal response. Al-dulaimi et al. 2025 is the best anchor here because it reports independent in vitro study and normal epithelial…
Modest sleep-architecture signal. Lyon 2011 is pediatric ADHD-specific, while Bulman 2025 found objective sleep measures less convincing than subjective sleep outcomes. That makes L-Theanine more defensible when sleep architecture is a real…
The evidence points to a plausible use case without proving a universal response. Schuster et al. 2025 is the best anchor here because it reports decentralized randomized trial, 165 randomized adults and…
Semaglutide may improve apnea-driven sleep fragmentation through weight loss, but this report has no strong polysomnography architecture endpoint. Kosiborod 2024 supports symptom improvement in obesity-related HFpEF with diabetes, which can indirectly affect…
Teichman 2006 reports CJC-1295 human pharmacology; supports sustained GH/IGF-1 increase and short-duration tolerability, not body-composition or longevity outcomes. Ionescu 2006 points in the same direction, but route, dose, baseline status, and outcome…
No direct sleep architecture trial was verified for EAA supplementation. Any sleep effect is indirect through training recovery, appetite stability, or tryptophan competition rather than measured REM, deep sleep, or awakenings.
Yamadera 2007 used polysomnography and reported sleep-efficiency and slow-wave-sleep changes with 3 g glycine. Collagen is an indirect glycine vehicle.
No direct sleep-architecture evidence exists. Metformin is not a sleep-stage intervention.
Sleep architecture earns a moderate score because Langade 2019 included objective sleep assessment and Cheah 2021 supports a sleep meta-analysis signal. Evidence is better than most adaptogens but not comparable to full…
No direct polysomnography, wearable sleep-stage, or sleep-architecture trial was found. Any sleep effect should be treated as secondary to cortisol timing and arousal state.
Sleep-stage evidence is thin. Community reports of more deep sleep after keto adaptation exist, but polysomnography data is not strong enough to score higher. Early restriction can reduce sleep continuity, and long-term…
No direct evidence on REM, deep sleep, sleep latency, or sleep efficiency. Score stays below neutral because the mechanism does not map cleanly to sleep architecture.
INSUFFICIENT_EVIDENCE for sleep architecture; any sleep tracking should be safety and response monitoring only.
No direct sleep-architecture evidence. Any effect would likely come through training fatigue, pain reduction, or mobility gains rather than a primary sleep mechanism.
Bedtime dosing tries to amplify the natural slow-wave-sleep GH pulse. The timing logic is coherent, but controlled sleep-architecture endpoints with tesamorelin have not established a robust clinical effect.
Sleep architecture is the one non-body-composition outcome MK-677 genuinely moved in controlled human work. In young subjects, 25 mg raised deep stage-IV sleep by roughly 50 percent and REM by over 20…
Fitness may improve slow-wave sleep over time. Late sessions can disrupt sleep architecture in sensitive users, so this remains timing-dependent.
Vivid dreams suggest REM-stage effects for some users, but no polysomnography study confirms sleep-architecture changes. Keep this as anecdotal until objective sleep-stage data exist.
TRT has no clear sleep-architecture benefit and can worsen sleep apnea. Men with snoring, daytime sleepiness, high hematocrit, or resistant hypertension need sleep evaluation before dose escalation.
Sleep architecture is the strongest mechanistic story around sermorelin and the weakest direct one. Growth-hormone-releasing hormone at the class level promotes deep non-REM sleep in human sleep paradigms, which is why pre-sleep…
Nothing matches those filters.
Monthly out-of-pocket cost at the most accessible legitimate channel, at the dose the score was given for. 5 of 24 are not priced yet; those cells are left blank rather than guessed.
| Intervention | Monthly cost | At dose | How you get it |
|---|---|---|---|
| Glycine | $2–$3 | 3 g oral glycine | Over the counter |
| Neurofeedback | Not priced yet | ||
| Tirzepatide | $299–$449 | 2.5 to 5 to 7.5 to 10 to 12.5 to 15 mg | Prescription |
| Zone 2 Cardio | Not priced yet | Over the counter | |
| Epitalon | $95–$1,100 | 5-10 mg/day subcutaneous | Grey market |
| L-Theanine | $3–$8 | 200 mg L-theanine + 100 mg caffeine | Over the counter |
| Saffron | Not priced yet | ||
| Semaglutide | $199–$349 | 0.25 mg weeks 1 to 4, 0.5 mg weeks 5 to 8, 1.0 mg weeks 9 to 12, 1.7 mg weeks 13 to 16, 2.4 mg week 17 onward | Prescription |
| CJC-1295 | $80–$200 | 1-2 mg subcutaneous | Grey market |
| Essential Amino Acids | Not priced yet | ||
| Collagen Peptides | $8–$40 | 2.5-10 g hydrolyzed collagen peptides | Over the counter |
| Metformin | $4–$30 | 500 mg with dinner for 1 week, then 500 mg twice daily for 1 week, then increase by 500 mg/week toward 1000 mg twice daily as tolerated | Prescription |
| Ashwagandha | $15–$30 | 300 mg KSM-66 with breakfast and 300 mg with dinner | Over the counter |
| Tongkat Ali | $20–$40 | 200 mg/day Physta standardized extract | Over the counter |
| Ketogenic Diet | $100 | Standard keto, 40-50 g total carbohydrate/day | Over the counter |
| Ca-AKG (Calcium Alpha-Ketoglutarate) | $15–$30 | 1 g/day generic Ca-AKG oral | Over the counter |
| Rapamycin | $15–$50 | 3 mg | Prescription |
| Whole-Body Vibration | $50–$100 | 30 Hz, roughly 0.3g, 10-20 min standing | Over the counter |
| Tesamorelin | $250–$500 | 2 mg subcutaneous daily in the evening | Prescription |
| MK-677 (Ibutamoren) | $30–$60 | 10 to 12.5 mg | Grey market |
| Norwegian 4×4 | Not priced yet | Over the counter | |
| Lion’s Mane | $20–$40 | 3 g/day fruiting body extract | Over the counter |
| TRT (Testosterone Replacement Therapy) | $50–$300 | Clinician-selected formulation at the lowest dose likely to restore physiologic testosterone | Prescription |
| Sermorelin (GHRH 1-29) | $129–$250 | 100 mcg | Prescription |
Head-to-head reports and category rankings that name a winner on this use case.
Both score anxiety 7.5–8.0/10, so the tie-breaker is time. L-theanine works in about an hour and you take it when you need it. Ashwagandha takes eight weeks and…
Tesamorelin, unless price is the only thing deciding. It is FDA-approved for visceral fat with Phase 3 trials behind it, while CJC-1295 is a gray-market research peptide whose…
Glycine, at 7.5–8.0 out of 10 for deep and rem sleep. Bannai 2012 anchors the most relevant signal.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 7.5–8.0 out of 10 for deep and rem sleep.
24 of the 84 interventions evaluated for deep and rem sleep score 3.0 out of 10 or better, which is the cut-off for appearing on this page.